Kilts to oversee Gillette/P&G integration
This article was originally published in The Tan Sheet
Gillette CEO James Kilts is stepping down as head of the blades and razors business effective July 1, P&G reports May 24. However, because "there is still a lot of work to do" regarding the Gillette integration, Kilts will continue with the company as vice chairman of P&G's board of directors until Oct. 1, a P&G spokesperson said. "Last year we planned the integration and the deal closed Oct. 1, so we're only about six months into the integration," he said. "There's still much more work ahead and [Kilts] will focus exclusively on that." P&G acquired Gillette Oral Care last year in a $57 bil. transaction (1"The Tan Sheet" Oct. 10, 2005, p. 13). Kilts will retire upon the Oct. 1 culmination of his duties, the firm noted; until then, he will continue reporting to President and CEO A.G. Lafley. The exec will be replaced by current President-Global Duracell & Braun Mark Leckie, who will assume his new position as group president-Gillette global business in July. Leckie will take on Kilts' day-to-day responsibilities, according to the firm...
You may also be interested in...
Procter & Gamble will focus on growing Gillette's brand equity and product offerings in the midterm, P&G CFO Clayt Daley told analysts during an Oct. 3 conference call. P&G's $57 bil. acquisition of Gillette closed Oct. 1, one day after receiving FTC approval
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.